Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: An AGICC clinical trial

被引：0

作者：

Cohen, Deirdre J.

Goldberg, Judith D.

Leichman, Lawrence P.

Hochman, Tsivia

Newman, Elliot

Du, Kevin Lee

Megibow, Alec

Oberstein, Paul Eliezer

Al-Rajabi, Raed Moh'd Taiseer

Scott, Aaron J.

Bekaii-Saab, Tanios S.

Messersmith, Wells A.

Weekes, Colin D.

机构：

[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

[2] NYU, Grossman Sch Med, New York, NY USA

[3] NYU, Sch Med, New York, NY USA

[4] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA

[5] Northwell Hlth, New York, NY USA

[6] Yale Canc Ctr, New Haven, CT USA

[7] Univ Kansas, Med Ctr, Div Med Oncol, Kansas City, KS 66103 USA

[8] Univ Arizona, Tucson, AZ USA

[9] Mayo Clin, Comprehens Canc Ctr, Phoenix, AZ USA

[10] Univ Colorado, Aurora, CO USA

[11] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol Oncol, Dept Med, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4175

引用

页数：1

共 50 条

[31] Efficacy of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma
Kang, J.
Kim, K-P.
Yoo, C.
Lee, J-L.
Ryoo, B-Y.
Chang, H-M.
Lee, S. S.
Park, D. H.
Song, T. J.
Seo, D. W.
Lee, S. K.
Kim, M-H.
Hwang, D. W.
Song, K. B.
Lee, J. H.
Kim, S. C.
ANNALS OF ONCOLOGY, 2016, 27
[32] Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma
Trinh, Katherine, V
Fischer, Dawn A.
Gardner, Timothy B.
Smith, Kerrington D.
FRONTIERS IN ONCOLOGY, 2020, 10
[33] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
Alvarez, R.
Ales, I.
Diaz, R.
de Paredes, B. G.
Hidalgo, M.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10): : 1193 - 1198
[34] Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinoma
Lee, Hee Seung
An, Chansik
Hwang, Ho Kyoung
Roh, Yun Ho
Kang, Huapyong
Jo, Jung Hyun
Chung, Moon Jae
Park, Jeong Youp
Kang, Chang Moo
Park, Seung Woo
Yoon, Dong Sup
Lee, Woo Jung
Song, Si Young
Bang, Seungmin
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (03) : 499 - 507
[35] Initial Experience in the Treatment of "Borderline Resectable'' Pancreatic Adenocarcinoma
Busquets, Juli
Fabregat, Juan
Verdaguer, Helena
Laquente, Berta
Pelaez, Nuria
Secanella, Luis
Leiva, David
Serrano, Teresa
Cambray, Maria
Lopez-Urdiales, Rafael
Ramos, Emilio
CIRUGIA ESPANOLA, 2017, 95 (08): : 447 - 456
[36] Racial Disparity in Pancreatoduodenectomy for Borderline Resectable Pancreatic Adenocarcinoma
George Molina
Thomas E. Clancy
Thomas C. Tsai
Miranda Lam
Jiping Wang
Annals of Surgical Oncology, 2021, 28 : 1088 - 1096
[37] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
R. Álvarez
I. Alés
R. Díaz
B. G. de Paredes
M. Hidalgo
Clinical and Translational Oncology, 2017, 19 : 1193 - 1198
[38] OUTCOMES OF NEOADJUVANT CHEMORADIATION WITH AND WITHOUT SYSTEMIC CHEMOTHERAPY IN RESECTABLE AND BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA
Trinh, Katherine V.
Fischer, Dawn A.
Gardner, Timothy B.
Smith, Kerrington
GASTROENTEROLOGY, 2019, 156 (06) : S324 - S325
[39] Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
Barreto, Savio George
Shrikhande, Shailesh, V
Sirohi, Bhawna
INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (SUPPL 2) : 249 - 254
[40] Tumor downsizing following neoadjuvant therapy for borderline-resectable pancreatic adenocarcinoma
Reza, Joseph Arturo
Monreal, Alberto
Meyer, Patrick Hunter
Patel, Swati
Zakari, Ahmed
de la Fuente, Sebastian
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)

← 1 2 3 4 5 →